semaglutide alzheimer phase 3 Efficacy and safety of oral 14 mg (flexible dose) in early-stage symptomatic Alzheimer's disease (evoke and evoke+): two 3, randomised, placebo-controlled trials Alzheimer's disease drug development pipeline:

Li C, Liu J, Hou W, Kang R, Tang D

Before starting a treatment like Tirzepatide or Semaglutide, always discuss your medical history with the provider

This company wants to make it: Macklin, the weight management doctor, says improving access to generics could have societal benefits as well, because obesity is still so heavily stigmatized

AP announces stylebook changes

Success stories and a checklist for future directions are presented to encourage further research in this area

Here, well delve into the intricacies of maintaining GLP-1 medications, set expectations on how long patients should stay on GLP-1 medications, and offer insights into the best practices for patients looking to stop their GLP-1 journey